A+ = 95.0+
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Based on KLAS' Decision Insights data, the market energy indicator reflects the frequency with which a vendor is seriously considered and replaced compared to what would be expected based on the number of vendors in the market and the number of purchase decisions recorded.
Market average: 80.1
Software average: 79.6
Overall performance score (100-point scale) |
Trend (2023-2024) |
# of unique orgs |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
||
|
Bluesight (formerly Protenus)
Protenus Diversion Analytics 
|
85.5 |
-3%
|
18
|
B+
|
B+
|
B
|
B-
|
A
|
B+
|
|
| |
|
|
|
|
||||||
|
Bluesight
ControlCheck
|
84.4 |
-3%
|
42
|
B-
|
A-
|
B
|
B
|
B
|
B
|
|
| |
|
|
|
|
||||||
|
BD
HealthSight Diversion Management
|
78.9 |
-1%
|
29
|
C+
|
B-
|
B-
|
C+
|
B+
|
B-
|
|
| |
|
|
|
|
||||||
|
Imprivata
Drug Diversion Intelligence
|
70.4 |
+9%
|
17
|
C-
|
D+
|
C
|
C-
|
B-
|
C
|
|
50.0 |
100.0 |
|||||||||
culture
B+
loyalty
B+
operations
B
product
B-
relationship
A
value
B+
84.4
42
culture
B-
loyalty
A-
operations
B
product
B
relationship
B
value
B
culture
C+
loyalty
B-
operations
B-
product
C+
relationship
B+
value
B-
culture
C-
loyalty
D+
operations
C
product
C-
relationship
B-
value
C
Solutions Not Ranked
Ordered alphabetically
L
|
Overall Performance Score (100-point scale) |
# of unique orgs |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
|
|
Bluesight
RxAuditor Investigate / RxAuditor (formerly Medacist) L |
66.4 |
11
|
D+
|
F
|
C-
|
D
|
C+
|
C+
|
| |
|
|
|
|
||||
|
HelioMetrics
Drug Diversion Analytics L |
84 |
8
|
B+
|
B
|
B
|
B
|
A-
|
B+
|
| |
|
|
|
|
||||
|
Wolters Kluwer
Sentri7 Drug Diversion (formerly Invistics) L |
78.7 |
6
|
C
|
B-
|
C+
|
B-
|
B+
|
B
|
L
&nbps;
Bluesight
RxAuditor Investigate / RxAuditor (formerly Medacist) L
RxAuditor Investigate / RxAuditor (formerly Medacist) L
66.4
11
11
culture
D+
loyalty
F
operations
C-
product
D
relationship
C+
value
C+
HelioMetrics
Drug Diversion Analytics L
Drug Diversion Analytics L
84
8
8
culture
B+
loyalty
B
operations
B
product
B
relationship
A-
value
B+
Wolters Kluwer
Sentri7 Drug Diversion (formerly Invistics) L
Sentri7 Drug Diversion (formerly Invistics) L
78.7
6
6
culture
C
loyalty
B-
operations
C+
product
B-
relationship
B+
value
B
